Keytruda treatment found to cut risk of aggressive cancer returning after surgery by more than a third
Thousands of lives could be saved with a “promising” immunotherapy drug that can cut the risk of an aggressive form of breast cancer returning by more than a third, according to “exciting” results from a long-term global study.
Keytruda, also known as pembrolizumab, uses the patient’s own immune system to fight cancer. The drug works by helping the immune system recognise and attack cancer cells, and is already used to treat lung cancer, skin cancer, bladder cancer and Hodgkin lymphoma. It is administered in a solution via a drip into the patient’s bloodstream, with the number of sessions depending on the type of cancer.
Very nice blog post. I definitely love this site. Stick with it! https://yoykem.com.tr/
Thank you for empowering your readers to make a difference and inspiring us to take action through your passionate writing.
I love the way you presented the information in this article. Your writing is clear, concise, and easy to follow.
I’m always impressed by the level of research and detail you put into your articles. It shows how committed you are to providing high-quality content.
You have a talent for writing. Your article is engaging and thought-provoking.
Your writing style is so engaging and relatable. It feels like I’m having a conversation with a friend, rather than reading an article.
I like how you present the information in an easy to understand and structured way.
The author’s passion for the subject shines through in this article.
Your writing is inspiring and uplifting, and I always feel motivated and encouraged after reading your articles.
I’m glad to see that there are resources like this available to readers.